Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid prepared from a unit dose suspension
Details for Australian Patent Application No. 2004312095 (hide)
International Classifications
Event Publications
20 July 2006 PCT application entered the National Phase
PCT publication WO2005/065651 Priority application(s): WO2005/065651
14 August 2008 Alteration of Name
The name of the applicant has been altered to Cydex Pharmaceuticals, Inc.
16 October 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2004312096-Inhalant formulation containing sulfoalkyl ether gamma-cyclodextrin and corticosteroid
2004312090-Pharmaceutical composition for thrombin peptide derivatives
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser